Stay updated with breaking news from Treated Cases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DelveInsight's analysis estimates that the postherpetic neuralgia market is expected to show positive growth, mainly attributed to increased incidence and the anticipated launch of novel therapies
Currently, several emerging therapies, such as retifanlimab, BMX-001, LCB84, KEYTRUDA (pembrolizumab), and others, are being evaluated in late-stage and mid-stage clinical trials. The successful
/PRNewswire/ -- DelveInsight's Usher Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, Usher syndrome...
/PRNewswire/ -- DelveInsight's Giant-Cell Arteritis Market Insights report includes a comprehensive understanding of current treatment practices, giant-cell...
/PRNewswire/ -- DelveInsight's Retinitis Pigmentosa Market Insights report includes a comprehensive understanding of current treatment practices, retinitis...